Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction.Avidity Biosciences, Inc. (Nasdaq: RNA) announced that it has agreed to sell 15,224,773 shares…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
